Market Closed -
TEL AVIV STOCK EXCHANGE
07:24:08 2024-04-25 am EDT
|
5-day change
|
1st Jan Change
|
25,610
ILa
|
-2.07%
|
|
-1.46%
|
-8.86%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
6,978
|
10,460
|
8,278
|
13,767
|
11,944
|
13,346
|
Enterprise Value (EV)
1 |
16,730
|
19,894
|
17,730
|
24,287
|
22,274
|
24,311
|
P/E ratio
|
11.9
x
|
7.76
x
|
-33.1
x
|
9.34
x
|
8.59
x
|
12.9
x
|
Yield
|
3.45%
|
2.39%
|
-
|
-
|
3.68%
|
1.8%
|
Capitalization / Revenue
|
4.38
x
|
6.58
x
|
7.41
x
|
9.13
x
|
6.78
x
|
7.27
x
|
EV / Revenue
|
10.5
x
|
12.5
x
|
15.9
x
|
16.1
x
|
12.6
x
|
13.2
x
|
EV / EBITDA
|
14.9
x
|
18.2
x
|
24.5
x
|
22.6
x
|
18
x
|
19.1
x
|
EV / FCF
|
42.1
x
|
68.4
x
|
64.9
x
|
-36.3
x
|
12.7
x
|
55.3
x
|
FCF Yield
|
2.38%
|
1.46%
|
1.54%
|
-2.75%
|
7.86%
|
1.81%
|
Price to Book
|
1.16
x
|
1.4
x
|
1.15
x
|
1.59
x
|
1.21
x
|
1.27
x
|
Nbr of stocks (in thousands)
|
44,786
|
47,436
|
47,439
|
47,473
|
47,473
|
47,496
|
Reference price
2 |
155.8
|
220.5
|
174.5
|
290.0
|
251.6
|
281.0
|
Announcement Date
|
2/20/19
|
2/26/20
|
3/11/21
|
3/14/22
|
3/13/23
|
3/11/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,593
|
1,590
|
1,117
|
1,508
|
1,762
|
1,837
|
EBITDA
1 |
1,120
|
1,096
|
724
|
1,077
|
1,237
|
1,271
|
EBIT
1 |
1,117
|
1,093
|
720
|
1,070
|
1,216
|
1,208
|
Operating Margin
|
70.11%
|
68.74%
|
64.46%
|
70.95%
|
69.01%
|
65.76%
|
Earnings before Tax (EBT)
1 |
797.3
|
1,778
|
-247
|
2,000
|
1,801
|
1,362
|
Net income
1 |
584.4
|
1,276
|
-250
|
1,473
|
1,391
|
1,037
|
Net margin
|
36.68%
|
80.25%
|
-22.38%
|
97.68%
|
78.94%
|
56.45%
|
EPS
2 |
13.10
|
28.42
|
-5.270
|
31.04
|
29.30
|
21.81
|
Free Cash Flow
1 |
397.6
|
290.9
|
273.1
|
-668.4
|
1,752
|
439.2
|
FCF margin
|
24.96%
|
18.29%
|
24.45%
|
-44.32%
|
99.4%
|
23.91%
|
FCF Conversion (EBITDA)
|
35.51%
|
26.54%
|
37.72%
|
-
|
141.59%
|
34.56%
|
FCF Conversion (Net income)
|
68.04%
|
22.8%
|
-
|
-
|
125.92%
|
42.36%
|
Dividend per Share
2 |
5.368
|
5.272
|
-
|
-
|
9.266
|
5.052
|
Announcement Date
|
2/20/19
|
2/26/20
|
3/11/21
|
3/14/22
|
3/13/23
|
3/11/24
|
Fiscal Period: December |
2022 Q3
|
---|
Net sales
|
-
|
EBITDA
|
-
|
EBIT
|
-
|
Operating Margin
|
-
|
Earnings before Tax (EBT)
|
-
|
Net income
1 |
220
|
Net margin
|
-
|
EPS
2 |
4.640
|
Dividend per Share
|
-
|
Announcement Date
|
11/23/22
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
9,752
|
9,434
|
9,452
|
10,520
|
10,330
|
10,965
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
8.709
x
|
8.608
x
|
13.06
x
|
9.768
x
|
8.351
x
|
8.627
x
|
Free Cash Flow
1 |
398
|
291
|
273
|
-668
|
1,752
|
439
|
ROE (net income / shareholders' equity)
|
9.8%
|
18.8%
|
-3.15%
|
18.5%
|
14.8%
|
9.82%
|
ROA (Net income/ Total Assets)
|
3.55%
|
3.28%
|
2.08%
|
2.91%
|
3.04%
|
2.87%
|
Assets
1 |
16,467
|
38,844
|
-12,013
|
50,579
|
45,812
|
36,153
|
Book Value Per Share
2 |
134.0
|
158.0
|
152.0
|
183.0
|
208.0
|
222.0
|
Cash Flow per Share
2 |
5.600
|
21.00
|
20.40
|
22.30
|
11.40
|
13.20
|
Capex
1 |
2.79
|
3
|
2
|
7
|
22
|
23
|
Capex / Sales
|
0.18%
|
0.19%
|
0.18%
|
0.46%
|
1.25%
|
1.25%
|
Announcement Date
|
2/20/19
|
2/26/20
|
3/11/21
|
3/14/22
|
3/13/23
|
3/11/24
|
Last Close Price
256.1
ILS Average target price
352
ILS Spread / Average Target +37.45% Consensus |